753 related articles for article (PubMed ID: 15522252)
1. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
[TBL] [Abstract][Full Text] [Related]
2. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia.
Woodward ND; Jayathilake K; Meltzer HY
Schizophr Res; 2007 Feb; 90(1-3):86-96. PubMed ID: 17123785
[TBL] [Abstract][Full Text] [Related]
3. Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia.
Bosia M; Bechi M; Marino E; Anselmetti S; Poletti S; Cocchi F; Smeraldi E; Cavallaro R
Neurosci Lett; 2007 May; 417(3):271-4. PubMed ID: 17383818
[TBL] [Abstract][Full Text] [Related]
4. COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
Neuhaus AH; Opgen-Rhein C; Urbanek C; Hahn E; Ta TM; Seidelsohn M; Strathmann S; Kley F; Wieseke N; Sander T; Dettling M
Pharmacopsychiatry; 2009 Jul; 42(4):141-4. PubMed ID: 19585392
[TBL] [Abstract][Full Text] [Related]
5. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
[TBL] [Abstract][Full Text] [Related]
6. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.
Goldberg TE; Egan MF; Gscheidle T; Coppola R; Weickert T; Kolachana BS; Goldman D; Weinberger DR
Arch Gen Psychiatry; 2003 Sep; 60(9):889-96. PubMed ID: 12963670
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
[TBL] [Abstract][Full Text] [Related]
8. Catechol O-methyltransferase Val158Met polymorphism is associated with cognitive performance in nondemented adults.
de Frias CM; Annerbrink K; Westberg L; Eriksson E; Adolfsson R; Nilsson LG
J Cogn Neurosci; 2005 Jul; 17(7):1018-25. PubMed ID: 16102234
[TBL] [Abstract][Full Text] [Related]
9. Effect of catechol O-methyltransferase val(158)met polymorphism on the p50 gating endophenotype in schizophrenia.
Lu BY; Martin KE; Edgar JC; Smith AK; Lewis SF; Escamilla MA; Miller GA; Cañive JM
Biol Psychiatry; 2007 Oct; 62(7):822-5. PubMed ID: 17448448
[TBL] [Abstract][Full Text] [Related]
10. The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.
Szegedi A; Rujescu D; Tadic A; Müller MJ; Kohnen R; Stassen HH; Dahmen N
Pharmacogenomics J; 2005; 5(1):49-53. PubMed ID: 15520843
[TBL] [Abstract][Full Text] [Related]
11. Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men.
Smyrnis N; Avramopoulos D; Evdokimidis I; Stefanis CN; Tsekou H; Stefanis NC
Biol Psychiatry; 2007 Apr; 61(7):845-53. PubMed ID: 17123481
[TBL] [Abstract][Full Text] [Related]
12. Variations in the catechol O-methyltransferase polymorphism and prefrontally guided behaviors in adolescents.
Wahlstrom D; White T; Hooper CJ; Vrshek-Schallhorn S; Oetting WS; Brott MJ; Luciana M
Biol Psychiatry; 2007 Mar; 61(5):626-32. PubMed ID: 17014828
[TBL] [Abstract][Full Text] [Related]
13. Catechol-O-methyl transferase and schizophrenia.
Sagud M; Mück-Seler D; Mihaljević-Peles A; Vuksan-Cusa B; Zivković M; Jakovljević M; Pivac N
Psychiatr Danub; 2010 Jun; 22(2):270-4. PubMed ID: 20562760
[TBL] [Abstract][Full Text] [Related]
14. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
[TBL] [Abstract][Full Text] [Related]
16. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
[TBL] [Abstract][Full Text] [Related]
17. Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.
Ho BC; Wassink TH; O'Leary DS; Sheffield VC; Andreasen NC
Mol Psychiatry; 2005 Mar; 10(3):229, 287-98. PubMed ID: 15668720
[TBL] [Abstract][Full Text] [Related]
18. Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning.
Gosso MF; de Geus EJ; Polderman TJ; Boomsma DI; Heutink P; Posthuma D
Eur J Hum Genet; 2008 Sep; 16(9):1075-82. PubMed ID: 18382477
[TBL] [Abstract][Full Text] [Related]
19. Impact of catechol-O-methyltransferase Val(108/158) Met genotype on hippocampal and prefrontal gray matter volume.
Cerasa A; Gioia MC; Labate A; Liguori M; Lanza P; Quattrone A
Neuroreport; 2008 Mar; 19(4):405-8. PubMed ID: 18287936
[TBL] [Abstract][Full Text] [Related]
20. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
